Abstract
DCK lactam analogues were synthesized and evaluated for anti-HIV activity against HIV-1 replication in H9 lymphocyte cells. 4-Methyl-DCK lactam (11a) exhibited potent anti-HIV activity with EC50 and therapeutic index values of 0.00024 microM and 119,333, respectively.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / pharmacology*
-
Biochemistry / methods
-
Bridged Bicyclo Compounds, Heterocyclic / chemistry*
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
-
Camphor / analogs & derivatives*
-
Camphor / chemical synthesis
-
Camphor / pharmacology
-
Coumarins / chemistry*
-
Coumarins / pharmacology*
-
Drug Evaluation, Preclinical / methods
-
Humans
-
Lactams / chemistry
-
Lymphocytes / drug effects
-
Lymphocytes / virology
-
Quinolones / chemical synthesis*
-
Quinolones / pharmacology*
-
Structure-Activity Relationship
Substances
-
3',4'-di-O-camphanoyl-4-methylkhellactone
-
3',4'-di-O-camphanoyl-4-methylkhellactone lactam
-
Anti-HIV Agents
-
Bridged Bicyclo Compounds, Heterocyclic
-
Coumarins
-
Lactams
-
Quinolones
-
Camphor